Copyright
©The Author(s) 2025.
World J Diabetes. Aug 15, 2025; 16(8): 108101
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.108101
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.108101
Table 1 Antibody information used for western blot analysis
Antibody name | Manufacturers | CAS | Molecular weight (kDa) | Species | Dilution ratio |
ACTIN | Servicebio | GB15003 | 42 | Rabbit | 1:1000 |
Occludin | Servicebio | GB111401 | 59 | Rabbit | 1:500 |
Claudin 1 | servicebio | GB11032 | 20 | Rabbit | 1:500 |
CRP | ABCLONAL | A0224 | 25 | Rabbit | 1:500 |
CREB3 L3 | Biorbyt | orb382910 | 49 | Rabbit | 1:500 |
N-cadherin | servicebio | GB111273 | 140 | Rabbit | 1:500 |
Vimentin | Servicebio | GB111308 | 54 | Rabbit | 1:500 |
E-cadherin | Servicebio | GB11082 | 135 | Rabbit | 1:500 |
Table 2 Information on primers
Genes | Direction | Sequence (5’→3’) |
CREB3 L3 | Forward | ATCCTGGCAACTCTTGCTCC |
CREB3 L3 | Reverse | AGGTGATGCTGTTGCAGGTC |
GAPDH | Forward | GAGTCAACGGATTTGGTCGT |
GAPDH | Reverse | GACAAGCTTCCCGTTCTCAG |
Table 3 Sequence of small interfering RNAs
Gene name | Sense sequence (5'--3') | Antisense sequence (5'--3') |
si-NC | ACGUGACACGUUCGGAGAA | UUCUCCGAACGUGUCACGU |
si-CREB3 L3-1 | GGAAGAAGAAGAAGGAAUAUA | UAUUCCUUCUUCUUCUUCCUG |
si-CREB3 L3-2 | CGAGAAGAGUCUCCAGGAAGC | UUCCUGGAGACUCUUCUCGGG |
si-CREB3 L3-3 | GUACGAGUGUUCUCCAGAACU | UUCUGGAGAACACUCGUACAG |
Table 4 Top 10 differentially upregulated and downregulated mRNAs involved in the inflammation pathways of bladder urothelium that are differentially expressed between patients with diabetic cystopathy and healthy controls by RNA sequencing analyses
Ensemble Gene ID | Gene name | Log2Fold change | P value | Regulation |
ENSG00000173432 | SAA1 | 9.14073 | 0.00000 | Up |
ENSG00000007171 | NOS2 | 7.36349 | 0.00141 | Up |
ENSG00000102794 | ACOD1 | 7.16781 | 0.00226 | Up |
ENSG00000163221 | S100A12 | 7.06422 | 0.00001 | Up |
ENSG00000123838 | C4BPA | 6.64444 | 0.00071 | Up |
ENSG00000112115 | IL17A | 6.23562 | 0.01454 | Up |
ENSG00000164485 | IL22RA2 | 6.02855 | 0.00162 | Up |
ENSG00000060566 | CREB3 L3 | 5.75447 | 0.01491 | Up |
ENSG00000177455 | CD19 | 5.62606 | 0.00004 | Up |
ENSG00000131203 | IDO1 | 5.55962 | 0.00000 | Up |
ENSG00000006128 | TAC1 | -3.38685 | 0.00907 | Down |
ENSG00000143502 | SUSD4 | -2.17976 | 0.00717 | Down |
ENSG00000175344 | CHRNA7 | -2.17060 | 0.00039 | Down |
ENSG00000118432 | CNR1 | -2.08059 | 0.00014 | Down |
ENSG00000172458 | IL17D | -2.01522 | 0.00173 | Down |
ENSG00000091831 | ESR1 | -1.97610 | 0.01013 | Down |
ENSG00000117335 | CD46 | -1.69696 | 0.00128 | Down |
ENSG00000132170 | PPARG | -1.65880 | 0.01276 | Down |
ENSG00000107485 | GATA3 | -1.53300 | 0.00175 | Down |
ENSG00000168329 | CX3CR1 | -1.47299 | 0.02335 | Down |
- Citation: Wu QG, Zhang MJ, Lan YB, Ma CL, Fu WJ. Hyperglycemia-induced overexpression of CREB3 L3 promotes the epithelial-to-mesenchymal transition in bladder urothelial cells in diabetes mellitus. World J Diabetes 2025; 16(8): 108101
- URL: https://www.wjgnet.com/1948-9358/full/v16/i8/108101.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i8.108101